Global Radiation Syndrome Treatment Market Outlook to 2023: Projected to Expand at a CAGR of 6%+

World News: . []

Dublin, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The report has been added to offering.

The radiation syndrome treatment market will register a CAGR of more than 6% by 2023.

The latest trend gaining momentum in the market is the advent of regenerative therapy. According to the report, one of the major drivers for this market is the increase in nuclear testing. Further, the report states that one of the major factors hindering the growth of this market is the difficulty to diagnose radiation syndrome.

The advent of regenerative therapy is expected to help the market grow. The global radiation syndrome treatment market has seen strong advances in terms of treatment options. The advent of regenerative medicines such as stem-cell therapy is one among such advances. In stem-cell therapy, the stem cells are taken from the patient and are re-inserted to replace the damaged cells to treat or prevent a disease.

The market appears to be fragmented and with the presence of several companies including Amgen and Neumedicines the competitive environment is quite intense. Factors such as the increase in nuclear testing and the advent of regenerative therapy, will provide considerable growth opportunities to radiation syndrome treatment manufactures.

With the presence of a considerable number of companies, this market appears to be fragmented. The market is expected to witness the emergence of many international and regional radiation syndrome therapeutic companies who offer therapeutics for the treatment of HSC syndrome, CNS syndrome, GI syndrome, and cardiovascular syndrome caused by radiation poisoning.

For more information about this report visit

Research and Markets also offers services providing focused, comprehensive and tailored research.


CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery

More news and information about Research and Markets

Published By:

Globe Newswire: 09:55 GMT Thursday 6th December 2018

Published: .

Search for other references to "global" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us